We are live on ! Find out more
CNCE

Concert Pharmaceuticals, Inc.
CNCE

Delisted

CNCE was delisted on the 3rd of March, 2023.

Back to rankings

91 hedge funds and large institutions have $214M invested in Concert Pharmaceuticals, Inc. in 2020 Q2 according to their latest regulatory filings, with 22 funds opening new positions, 32 increasing their positions, 25 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

120% more first-time investments, than exits

New positions opened: 22 | Existing positions closed: 10

28% more repeat investments, than reductions

Existing positions increased: 32 | Existing positions reduced: 25

22% more capital invested

Capital invested by funds: $175M → $214M (+$38.7M)

15% more funds holding

Funds holding: 79 → 91 (+12)

Holders
91
Holders Change
+12
Holders Change %
+15.19%
% of All Funds
1.87%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
22
Increased
32
Reduced
25
Closed
10
Calls
$263K
Puts
–
Net Calls
+$263K
Net Calls Change
-$205K

Top Buyers

Rank Fund Capital Flow
1
SW
SVB Wealth
Massachusetts
+$3.66M
2
EP
Eversept Partners
New York
+$2.23M
3
Point72 Asset Management
Point72 Asset Management
Connecticut
+$1.77M
4
Millennium Management
Millennium Management
New York
+$1.04M
5
Massachusetts Financial Services
Massachusetts Financial Services
Massachusetts
+$784K

Top Sellers

Rank Fund Capital Flow
1
SFM
Sphera Funds Management
Israel
-$3M
2
ISL
Ingalls & Snyder LLC
New York
-$707K
3
Citadel Advisors
Citadel Advisors
Florida
-$692K
4
BCM
Bridgeway Capital Management
Texas
-$510K
5
N
Nuveen
North Carolina
-$415K
Name Holding Trade Value Shares
Change 		Change in
Stake
Acadian Asset Management
26
Acadian Asset Management
Massachusetts
$1.58M -$247K -25,732 -14%
Two Sigma Advisers
27
Two Sigma Advisers
New York
$1.23M +$4.72K +492 +0.4%
JP Morgan Chase
28
JP Morgan Chase
New York
$1.15M -$160K -16,635 -13%
Bank of New York Mellon
29
Bank of New York Mellon
New York
$1.02M +$19.6K +2,039 +2%
Massachusetts Financial Services
30
Massachusetts Financial Services
Massachusetts
$813K +$784K +81,743 New
SPIA
31
Steward Partners Investment Advisory
New York
$780K +$59.1K +6,165 +9%
Man Group
32
Man Group
United Kingdom
$725K -$111K -11,587 -14%
Charles Schwab
33
Charles Schwab
California
$717K +$46.7K +4,873 +7%
Invesco
34
Invesco
Georgia
$714K -$31K -3,233 -4%
Wells Fargo
35
Wells Fargo
California
$700K +$224K +23,345 +50%
California Public Employees Retirement System
36
California Public Employees Retirement System
California
$631K -$118K -12,316 -16%
MAM
37
Martingale Asset Management
Massachusetts
$617K +$594K +61,914 New
WG
38
Winton Group
United Kingdom
$592K -$10.9K -1,132 -2%
UBS Group
39
UBS Group
Switzerland
$513K -$70.9K -7,397 -13%
Axa
40
Axa
France
$462K -$265K -27,628 -37%
Citigroup
41
Citigroup
New York
$461K +$363K +37,886 +450%
RhumbLine Advisers
42
RhumbLine Advisers
Massachusetts
$456K +$52.4K +5,466 +14%
Two Sigma Investments
43
Two Sigma Investments
New York
$439K -$98.1K -10,228 -19%
California State Teachers Retirement System (CalSTRS)
44
California State Teachers Retirement System (CalSTRS)
California
$420K +$14.3K +1,490 +4%
State of Wisconsin Investment Board
45
State of Wisconsin Investment Board
Wisconsin
$412K – – –
AA
46
ALPS Advisors
Colorado
$403K -$111K -11,535 -22%
AllianceBernstein
47
AllianceBernstein
Tennessee
$401K +$41.2K +4,300 +12%
Ameriprise
48
Ameriprise
Minnesota
$384K -$3.69K -385 -1%
Bessemer Group
49
Bessemer Group
New Jersey
$365K +$352K +36,700 New
Truist Financial
50
Truist Financial
North Carolina
$356K – – –
1
2
3 4 5

CNCE Hedge Fund Activity: Q2 2020 in Review

91 of the 4,878 institutional investors tracked by Wall St. Rank reported a position in Concert Pharmaceuticals, Inc. (CNCE) for Q2 2020, worth a combined $214M — up 22% from $175M a quarter earlier.

Buyers outnumbered sellers: 22 funds opened new CNCE positions and 10 closed out — a net gain of 12 holders — while 32 added to existing stakes and 25 trimmed.

The largest buyer was SVB Wealth, opening a new position worth an estimated $3.66M. The largest seller was Sphera Funds Management, cutting an estimated $3M.

  • 91 institutional investors held Concert Pharmaceuticals, Inc. (CNCE) as of Q2 2020, up from 79 in Q1 2020.
  • Funds reported $214M of Concert Pharmaceuticals, Inc. stock for Q2 2020, up 22% quarter-over-quarter.
  • 22 funds opened new Concert Pharmaceuticals, Inc. positions in Q2 2020 and 10 closed out, a net change of +12 holders.
  • The largest Concert Pharmaceuticals, Inc. buyer in Q2 2020 was SVB Wealth, an estimated $3.66M added.
  • The largest Concert Pharmaceuticals, Inc. seller in Q2 2020 was Sphera Funds Management, an estimated $3M sold.

Based on aggregated 13F filings for Q2 2020.